ALDH1A1 and prostate carcinoma: Interestingly, PLA2G7 silencing reduced the expression of aldehyde dehydrogenase 1A1 (ALDH1A1) (Figure 2E), described as a prostate cancer stem cell marker and associated with poor prostate cancer outcome [23, 24].